ArticleJAC-antimicrobial resistance2021

TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogen

Jason E Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.